Safety and Efficacy of Treatment with Dupilumab for up to 2 Years in Infants and Young Children with Atopic Dermatitis.

Paller AS, Simpson EL, Siegfried EC, Cork MJ, Arkwright PD, Pinter A, Deleuran M, Hong HC, Ma Y, Bansal A, Dubost-Brama A, Nguyen TV

Open source

DOI
10.1007/s40257-026-01018-1
Published
2026 May
Container
American journal of clinical dermatology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40257-026-01018-1,
  title = {Safety and Efficacy of Treatment with Dupilumab for up to 2 Years in Infants and Young Children with Atopic Dermatitis.},
  author = {Paller AS and Simpson EL and Siegfried EC and Cork MJ and Arkwright PD and Pinter A and Deleuran M and Hong HC and Ma Y and Bansal A and Dubost-Brama A and Nguyen TV},
  year = {2026},
  journal = {American journal of clinical dermatology},
  doi = {10.1007/s40257-026-01018-1},
  url = {https://doi.org/10.1007/s40257-026-01018-1}
}

RIS

TY  - JOUR
TI  - Safety and Efficacy of Treatment with Dupilumab for up to 2 Years in Infants and Young Children with Atopic Dermatitis.
AU  - Paller AS
AU  - Simpson EL
AU  - Siegfried EC
AU  - Cork MJ
AU  - Arkwright PD
AU  - Pinter A
AU  - Deleuran M
AU  - Hong HC
AU  - Ma Y
AU  - Bansal A
AU  - Dubost-Brama A
AU  - Nguyen TV
PY  - 2026
JO  - American journal of clinical dermatology
DO  - 10.1007/s40257-026-01018-1
UR  - https://doi.org/10.1007/s40257-026-01018-1
ER  - 

APA

AS, P., EL, S., EC, S., MJ, C., PD, A., A, P., M, D., HC, H., Y, M., A, B., A, D., & TV, N. (2026). Safety and Efficacy of Treatment with Dupilumab for up to 2 Years in Infants and Young Children with Atopic Dermatitis.. American journal of clinical dermatology. https://doi.org/10.1007/s40257-026-01018-1

Source records